<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<http://schema.org/SearchAction>
<http://www.genengnews.com/keywordsandtools/email/gen-news-highlights/novartis-to-license-phase-ii-anticlotting-therapy-from-portola-for-75m/7633/>